List view / Grid view




NICE says ‘no’ to alirocumab in draft guidance

8 February 2016 | By Victoria White

NICE was concerned that alirocumab had not been compared with the combination therapy of ezetimibe plus a statin and that trials of the drug were not able to provide robust information on cardiovascular outcomes...


FDA approves LDL cholesterol drug Repatha

28 August 2015 | By Victoria White

Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, has been approved by the FDA for some patients who are unable to get their LDL cholesterol under control with current treatment options...